Study identifier:D133HR00030
ClinicalTrials.gov identifier:NCT05939128
EudraCT identifier:N/A
CTIS identifier:N/A
A multicentre, single arm, non-interventional, observational, prospective study to assess the BRCA1/2m prevalence, treatment approaches and outcomes in HER2-negative high-risk early breast cancer patients in Russia
Breast Cancer
N/A
No
-
All
750
Observational
18 Years - n/a
Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Aug 2024 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|